A 2-year, open-label pilot study of adjunctive chromium in patients with treatment-resistant rapid-cycling bipolar disorder.
Amann
Benedikt L
BL
Mergl
Roland
R
Vieta
Eduard
E
Born
Christoph
C
Hermisson
Igor
I
Seemueller
Florian
F
Dittmann
Sandra
S
Grunze
Heinz
H
D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002712:Chlorides / Q000008:administration & dosage*; D017608:Chromium Compounds / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects
D000975:Antioxidants; D002712:Chlorides; D017608:Chromium Compounds; C017133:chromous chloride